Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Pharm Stat. 2023 Jan 10;22(3):508–519. doi: 10.1002/pst.2285

FIGURE 2.

FIGURE 2

Modeled treatment group contrast in ADAS-Cog for each study. All models assume unstructured variance-covariance.

ADAS-Cog, Alzheimer’s Disease Assessment Scale–Cognitive Subscale; MCI, Mild Cognitive Impairment